Published in Aliment Pharmacol Ther on February 01, 1997
Testing for Helicobacter pylori in dyspeptic patients suspected of peptic ulcer disease in primary care: cross sectional study. BMJ (2001) 2.62
Point of care testing. BMJ (2001) 2.59
Systematic review of near patient test evaluations in primary care. BMJ (1999) 1.57
New immunological assays for the diagnosis of Helicobacter pylori infection. Gut (1999) 1.02
Comparison of two rapid whole-blood tests for Helicobacter pylori infection in Chinese patients. J Clin Microbiol (1998) 1.00
Testing for Helicobacter pylori infection: validation and diagnostic yield of a near patient test in primary care. BMJ (1999) 0.99
In-practice evaluation of whole-blood Helicobacter pylori test: its usefulness in detecting peptic ulcer disease. Br J Gen Pract (2000) 0.93
Blood tests in the management of Helicobacter pylori infection. Italian Helicobacter pylori Study Group. Gut (1998) 0.90
GP testing for Helicobacter pylori. Aliment Pharmacol Ther (1997) 0.75
Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice. Ann Clin Microbiol Antimicrob (2016) 0.75
Beta-lactamase-producing, penicillin-resistant gonococcus. Lancet (1976) 10.90
Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin. Antimicrob Agents Chemother (1973) 8.83
Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin. Lancet (1990) 6.99
In vitro antibacterial activity of norfloxacin (MK-0366). Antimicrob Agents Chemother (1982) 6.97
Outbreak of hospital infection caused by contaminated autoclaved fluids. Lancet (1972) 6.85
Diagnosis of gonorrhoea by culture on a selective medium containing vancomycin, colistin, nystatin and trimethoprim (VCNT). A comparison with Gram-staining and immunofluorescence. Br J Vener Dis (1972) 5.87
Hands as route of transmission for Klebsiella species. Br Med J (1977) 5.13
In-vitro activity of twelve antibacterial agents against Neisseria gonorrhoeae. Lancet (1970) 5.05
In vitro antibacterial activity and susceptibility of cefsulodin, an antipseudomonal cephalosporin, to beta-lactamases. Antimicrob Agents Chemother (1980) 4.43
Treatment of gonorrhoea with three different antibiotic regimes: doxycycline 300 mg., procaine penicillin plus benzyl penicillin 2.4 m.u., benzyl penicillin 5 m.u. plus probenecid. Br J Vener Dis (1970) 3.95
API ZYM: a simple rapid system for the detection of bacterial enzymes. J Clin Pathol (1977) 3.88
Hormonal regulation of beta1,3-glucanase messenger RNA levels in cultured tobacco tissues. EMBO J (1985) 3.81
A single locus determines sensitivity to bacterial flagellin in Arabidopsis thaliana. Plant J (1999) 3.71
In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases. Antimicrob Agents Chemother (1980) 3.68
Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole. Antimicrob Agents Chemother (1976) 3.55
Gonorrhoea in women. Diagnostic, clinical, and laboratory aspects. Lancet (1978) 3.51
Evidence for N- and C-terminal processing of a plant defense-related enzyme: Primary structure of tobacco prepro-beta-1,3-glucanase. Proc Natl Acad Sci U S A (1988) 2.86
Determination of antibiotic sensitivities by the Sensititre system. J Clin Pathol (1978) 2.79
Pseudomonas aeruginosa cross-infection due to contaminated respiratory apparatus. Lancet (1965) 2.78
Anaerobic vaginosis (non-specific vaginitis): clinical, microbiological, and therapeutic findings. Lancet (1983) 2.75
Diagnosis of gonorrhoea in women. Br J Vener Dis (1976) 2.67
Food as a source of Klebsiella species for colonisation and infection of intensive care patients. J Clin Pathol (1978) 2.65
Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob Agents Chemother (1995) 2.62
The comparative in-vitro activity of eight newer quinolones and nalidixic acid. J Antimicrob Chemother (1986) 2.59
K-252a inhibits the response of tomato cells to fungal elicitors in vivo and their microsomal protein kinase in vitro. FEBS Lett (1990) 2.43
Pyogenic liver abscess caused by Streptococcus milleri. Lancet (1975) 2.37
Gardnerella vaginalis, anaerobes, and vaginal discharge. Lancet (1982) 2.34
Analysis of the effector functions of different populations of mucosal lymphocytes. Ann N Y Acad Sci (1983) 2.31
Gentamicin-resistant Klebsiella aerogenes in a urological ward. Lancet (1977) 2.30
Infective endocarditis, 1970-1979. A study of culture-positive cases in St. Thomas' Hospital. Q J Med (1980) 2.30
Identification of Pseudomonas aeruginosa in the clinical laboratory. J Med Microbiol (1969) 2.20
Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila. J Antimicrob Chemother (1986) 2.16
The susceptibility of Neisseria gonorrhoeae to cefoxitin sodium. J Antimicrob Chemother (1978) 2.16
Antibiotic sensitivity of gonococci and treatment of gonorrhoea in Uganda. Br J Vener Dis (1970) 2.12
Epidemic methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1988) 2.09
Group B streptococci in the female genital tract. Br Med J (1976) 2.04
Assessment of a selective medium for the isolation of Neisseria gonorrhoeae. Br J Vener Dis (1979) 2.01
Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. Br Med J (Clin Res Ed) (1985) 1.98
Microbiology of pyogenic liver abscess. Br Med J (Clin Res Ed) (1981) 1.97
The activity of penicillin and eight cephalosporins on Neisseria gonorrhoeae. J Antimicrob Chemother (1976) 1.96
The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin. J Antimicrob Chemother (1985) 1.96
Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method. J Antimicrob Chemother (2000) 1.95
The in-vitro activity of PD127,391, a new quinolone. J Antimicrob Chemother (1988) 1.95
Imported penicillinase producing Neisseria gonorrhoeae becomes endemic in London. Br J Vener Dis (1983) 1.91
Sensitivity of different ecotypes and mutants of Arabidopsis thaliana toward the bacterial elicitor flagellin correlates with the presence of receptor-binding sites. J Biol Chem (2001) 1.91
Serological grouping of streptococci by a slide coagglutination method. J Clin Pathol (1977) 1.88
Reassessment of histone gene expression during cell cycle in human cells by using homologous H4 histone cDNA. Proc Natl Acad Sci U S A (1979) 1.87
Necrobacillosis: a forgotten disease. Br Med J (Clin Res Ed) (1984) 1.87
Comparison of radiometric and gas capture system for blood cultures. J Clin Pathol (1986) 1.81
Ceftazidime--a new extended-spectrum cephalosporin. Lancet (1982) 1.79
European multicentre evaluation of a commercial system for identification of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1996) 1.79
Pseudomonas cepacia (multivorans) septicaemia in an intensive-care unit. Lancet (1971) 1.78
Ciprofloxacin for treating urethral gonorrhoea in men. Genitourin Med (1986) 1.78
Inactivation of stress induced 1-aminocyclopropane carboxylate synthase in vivo differs from substrate-dependent inactivation in vitro. Plant Physiol (1990) 1.73
Disinfection of gastrointestinal fibre endoscopes. Lancet (1974) 1.71
A hospital outbreak of antibiotic-resistant Acinetobacter anitratus: epidemiology and control. J Hosp Infect (1980) 1.69
Staff carriage of epidemic methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1989) 1.68
Specific, high affinity binding of chitin fragments to tomato cells and membranes. Competitive inhibition of binding by derivatives of chitooligosaccharides and a Nod factor of Rhizobium. J Biol Chem (1994) 1.67
The plant wound hormone systemin binds with the N-terminal part to its receptor but needs the C-terminal part to activate it. Plant Cell (1998) 1.66
The application of flow cytometry to the study of bacterial responses to antibiotics. J Med Microbiol (1993) 1.66
Serum gentamicin assay: a comparison and assessment of different methods. J Clin Pathol (1974) 1.65
Control of HIF-1{alpha} and vascular signaling in fetal lung involves cross talk between mTORC1 and the FGF-10/FGFR2b/Spry2 airway branching periodicity clock. Am J Physiol Lung Cell Mol Physiol (2010) 1.63
Bacteremia due to Escherichia coli: a study of 861 episodes. Rev Infect Dis (1991) 1.62
Metronidazole and anaerobic sepsis. Br Med J (1976) 1.62
Vancomycin for staphylococcal shunt site infections in patients on regular haemodialysis. Br Med J (1970) 1.59
Prophylactic peroperative intravenous metronidazole in elective colorectal surgery. Lancet (1979) 1.58
Importance of organisms producing broad-spectrum SHV-group beta-lactamases into the United Kingdom. J Antimicrob Chemother (1990) 1.57
4-Quinolone-resistant Neisseria gonorrhoeae in the United Kingdom. J Med Microbiol (1991) 1.54
N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics. J Antimicrob Chemother (1981) 1.52
beta-Lactamases and susceptibility to beta-lactam antibiotics in Escherichia coli. J Antimicrob Chemother (1992) 1.51
Anaerobic subareolar breast abscess. Lancet (1979) 1.49
Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics. Antimicrob Agents Chemother (1994) 1.49
Antibiotic susceptibilities of streptococci from the mouth and blood of patients treated with penicillin or lincomycin and clindamycin. J Med Microbiol (1976) 1.49
Acute bacterial infection in kwashiorkor and marasmus. Br Med J (1968) 1.48
Antibacterial action of ciprofloxacin. Antimicrob Agents Chemother (1995) 1.48
Epidemiological patterns of Klebsiella colonization and infection in an intensive care ward. J Hyg (Lond) (1978) 1.48
The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid. J Antimicrob Chemother (1984) 1.47
The causative organisms of septicaemia and their epidemiology. J Antimicrob Chemother (1990) 1.47
Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children and adolescents without structural heart disease. Pediatric EP Society, Radiofrequency Catheter Ablation Registry. Am J Cardiol (1997) 1.47
Perception of Rhizobium nodulation factors by tomato cells and inactivation by root chitinases. Proc Natl Acad Sci U S A (1994) 1.46
In-vitro antigonococcal activity of rosoxacin (WIN 35213). Br J Vener Dis (1981) 1.45
DNA sequence differences of ampD mutants of Citrobacter freundii. Antimicrob Agents Chemother (1995) 1.45
Activity of sulfamethoxazole and trimethoprim against Bacteroides fragilis. Antimicrob Agents Chemother (1976) 1.45
Sch 29482: in-vitro antibacterial activity and susceptibility to beta-lactamases. J Antimicrob Chemother (1982) 1.45
Running stability is enhanced by a proximo-distal gradient in joint neuromechanical control. J Exp Biol (2007) 1.43
Relative instability of cephaloridine to staphylococcal penicillinase. Nature (1965) 1.43
The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates. J Antimicrob Chemother (2001) 1.42
Elicitation of suspension-cultured tomato cells triggers the formation of phosphatidic acid and diacylglycerol pyrophosphate. Plant Physiol (2000) 1.41
The beta-lactamases of Bacteroides species. J Antimicrob Chemother (1981) 1.41
Gonorrhoea. Lancet (1970) 1.40
MIC audit for routine ciprofloxacin sensitivity testing. J Antimicrob Chemother (1993) 1.39
Advances in antibiotics. Practitioner (1969) 1.39
SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases. J Antimicrob Chemother (1981) 1.38
The identification of pseudomonads and related bacteria in a clinical laboratory. J Med Microbiol (1978) 1.37
Diversity of staphylococci exhibiting high-level resistance to mupirocin. J Med Microbiol (1990) 1.35
Anaerobic curved rods in vaginitis. Lancet (1982) 1.35
The bacterial elicitor flagellin activates its receptor in tomato cells according to the address-message concept. Plant Cell (2000) 1.32
Mechanisms of resistance to aminoglycosides in clinical isolates. J Antimicrob Chemother (1982) 1.30
Susceptibility of Bacteroides fragilis to trimethoprim and sulphamethoxazole. Lancet (1974) 1.30
Brucella melitensis endocarditis: successful treatment of an infected prosthetic mitral valve. Thorax (1974) 1.29